Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA)

Autoimmunity

Volumn 38, Issue 4, 2005, Pages 277-281

  Caputo, Mariela ^a   Cerrone, Gloria Edith ^a   López, Ariel Pablo ^a,b   Villalba, Anabel ^a   Krochik, Gabriela Andrea ^c   Cédola, Federico Norberto ^d   Targovnik, Héctor Manuel ^a   Frechtel, Gustavo Daniel ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d Department of Internal Medicine   (Argentina)

Author keywords

CTLA4; Diabetes; LADA; Polymorphism

Indexed keywords

ADENINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GUANINE; HLA DQ ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CODON; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DNA; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 22144457415     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930500158203     Document Type: Article

References (30)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331: 1428-1436.
2. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA. Latent autoimmune diabetes mellitus in adults (LADA), the role of antibodies to glutamic acid decarboxilase in diagnosis and prediction of insulin dependency. Diabetes Med 1994;11:299-303.
3. Shimada A, Imazu Y, Morinaga S, Funae O, Kasuga A, Atsumi Y, Matsuoka K. T cell insulitis found in anti GAD 65+ diabetes with residual β cell function. Diabetes Care 1999;22:615-617.
4. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al. A genome -wide search for human type 1 diabetes susceptibility genes. Nature 1994;371:130-136.
5. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, Smith AN, Sebag-Montefiore L, Merriman ME, Wilson AJ, Pritchard LE, Cucca F, Barnett AH, Bain SC, Todd JA. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1999;19:297-300.
6. Sanjeevi CB, Falorni A, Kockum I, Hagopian WA, Lernmark A. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Diabet Med 1996;13:209-217, Review.
7. Bennett ST, Lucassen AM, Gough SC, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, et al. Susceptibility to human type 1 diabetes at IDDM 2 determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995;9:284-292.
8. Pugliese A, Zeller M, Fernandez A, Jr, Zalcberg LJ, Bartlett RJ, Ricordi C, Pietropaolo M, Eisenbarth GS, Bennett ST, Patel DD. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15:293-297.
9. Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad JF, Rotter JI, Yang MC, She JX. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 1992;49:492-499.
10. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian diabetes registry. Hum Mol Genet 1996;5:1075-1080.
11. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991;147:1037-1044.
12. Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP. The role of CTLA4 in the regulation and initiation of T-cell responses. Immunol Rev 1996;153:27-46.
13. Donner H, Seidl C, Braun J, Siegmund T, Herwig J, Seifried E, Usadel KH, Badenhoop K. CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families. Diabetes 1998;47: 1158-1160.
14. Chistiakov DA, Savost'anov KV, Nosikov VV. CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population. BMC Genet. 2001;2(6), Epub 2001 Mar 27.
15. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, Tao YW, Beaurain G, Tao YW, Bach JF, Huang HS, Luo DF, Zeidler A, Rotter JI, Yang MC, Modilevsky T, Maclaren NK, She JX. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1987;6:1275-1282.
16. Murray MG, Thompson WF. Rapid isolation of high molecular - weight plant DNA. Nucleic Acid Res 1980; 8:4321-4325.
17. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1996;82:143-146.
18. Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, Fontaine P. CTLA4 49 A/G dimorphism and type 1 diabetes susceptibility: A French case-control study and segregation analysis. Evidence of a maternal effect. Eur J Immunogenet 2002;29:251-257.
19. Yanagawa T, Gomi K, Nakao EI, Inada S. CTLA4 gene polymorphism in Japanese patients with rheumatoid arthritis. J Rheumatol 2000;27:2740-2742.
20. Seidl C, Donner H, Fischer B, Usadel KH, Seifried E, Kaltwasser JP, Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998;51:62-66.
21. Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, Garcia A, Garcia-Lozano JR, Nunez-Roldan A. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 1999;53:296-300.
22. Cosentino A, Gambelunghe G, Tortoioli C, Falorni A. CTLA4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann NY Acad Sci 2002;958:337-340.
23. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC, Cordell HJ, Walker NM, Bordin C, Hulme J, Motzo C, Cucca F, Hess JF, Metzker ML, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie KM, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Maxwell AP, Carson DJ, Patterson CC, Franklyn JA, Clayton DG, Peterson LB, Wicker LS, Todd JA, Gough SC. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423:506-511, Epub 2003 Apr 30.
24. Anjos S, Polychronakos C. Mechanisms of genetic susceptibility to type I diabetes: Beyond HLA. Mol Genet Metab 2004;81:187-195.
25. Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem. 2002;277:46478-46486, Epub 2002 Sep 19.
26. Cerrone GE, Caputo M, Lopez AP, Gonzalez C, Massa C, Cedola N, Targovnik HM, Frechtel GD. Variable number of tandem repeats of the insulin gene determines susceptibility to latent autoimmune diabetes in adult. Mol Diagn 2004;8:43-49.
27. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol 2003;56:1-10, Review.
28. Moustakas AK, Papadopoulos GK. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: Keys to the fate of islet beta-cells. Am J Med Genet 2002;115:37-47, Review.
29. Abe T, Yamaguchi Y, Takino H, Fujita N, Yamauchi-Degawa M, Ozaki M, Yamakawa K, Sera Y, Sakamaki H, Uotani S, Kawasaki E, Awata T, Yamasaki H, Eguchi K. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: Genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody. Diabet Med Sep 2001;18:726-731.
30. Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur J Hum Genet Jan 2003;11:81-84.